Editing Suffern, New York (section)

== Economy ==
[[Novartis]] had a manufacturing facility in Suffern, employing approximately 525 workers.<ref name=geneng20140215>{{cite news | title=Novartis Shutting Down Suffern, NY, Plant | type=paper | work=[[Gen. Eng. Biotechnol. News]] | page=24 | volume=34 | issue=4 | date=February 15, 2014 | department=News: Bioprocessing }}</ref>  In January 2014, the company announced closure of this facility by 2017, citing loss of patent exclusivity on [[Diovan]] as a major factor in the decision.<ref name=geneng20140215/><ref name=20F2013>{{cite web | url=https://www.sec.gov/Archives/edgar/data/1114448/000104746914000415/a2217883z20-f.htm | title=FORM 20-F | date=January 29, 2014 | website=[[EDGAR]] | publisher=U.S. Securities and Exchange Commission }}</ref>{{rp|54}}  The facility was engaged in the "production of tablets, capsules, vials and inhalation products".<ref name=20F2013/>{{rp|99}}

[[Avon Products|Avon's]] Global Research and Development facility is located in Suffern, employing 350 scientists and technicians in developing cosmetics.<ref name=Avon>{{cite web | url=http://www.avoncompany.com/Brands/index.html | title=Leading Global Brands | date=July 28, 2014 | website=[[Avon Products]] | publisher=Avon Products }}</ref>